DK2294012T3 - Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom - Google Patents
Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdomInfo
- Publication number
- DK2294012T3 DK2294012T3 DK09743658.8T DK09743658T DK2294012T3 DK 2294012 T3 DK2294012 T3 DK 2294012T3 DK 09743658 T DK09743658 T DK 09743658T DK 2294012 T3 DK2294012 T3 DK 2294012T3
- Authority
- DK
- Denmark
- Prior art keywords
- bowel
- antibiotic
- administration
- treatment
- cleanser
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5134108P | 2008-05-07 | 2008-05-07 | |
| PCT/US2009/043138 WO2009137672A1 (en) | 2008-05-07 | 2009-05-07 | Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2294012T3 true DK2294012T3 (da) | 2014-10-06 |
Family
ID=41265004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09743658.8T DK2294012T3 (da) | 2008-05-07 | 2009-05-07 | Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20090324736A1 (da) |
| EP (1) | EP2294012B1 (da) |
| JP (1) | JP5752032B2 (da) |
| AU (1) | AU2009244190B2 (da) |
| CA (1) | CA2723752A1 (da) |
| DK (1) | DK2294012T3 (da) |
| ES (1) | ES2509892T3 (da) |
| HR (1) | HRP20140939T1 (da) |
| PL (1) | PL2294012T3 (da) |
| PT (1) | PT2294012E (da) |
| SI (1) | SI2294012T1 (da) |
| WO (1) | WO2009137672A1 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| EP2069363B1 (en) | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
| US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| WO2009108730A2 (en) | 2008-02-25 | 2009-09-03 | Salix Pharmaceuticals, Ltd. | Forms of rifaximin and uses thereof |
| US9603876B2 (en) | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| US8916193B2 (en) | 2008-12-10 | 2014-12-23 | Cipla Limited | Rifaximin complexes |
| RU2012126084A (ru) * | 2009-11-23 | 2013-12-27 | Сипла Лимитед | Пенная композиция для местного применения |
| US8532349B2 (en) | 2010-02-02 | 2013-09-10 | Omnivision Technologies, Inc. | Encapsulated image acquisition devices having on-board data storage, and systems, kits, and methods therefor |
| ES2951828T3 (es) | 2010-09-23 | 2023-10-25 | Leading Biosciences Inc | Administración de inhibidores de serina proteasa al estómago |
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| US8778907B2 (en) | 2011-04-27 | 2014-07-15 | Cumberland Pharmaceuticals | Lactulose for bowel evacuation |
| EP2874624B8 (en) * | 2012-07-17 | 2019-10-02 | Bayer New Zealand Limited | Injectable antibiotic formulations and their methods of use |
| KR20170098980A (ko) | 2012-09-11 | 2017-08-30 | 노어긴 비.브이. | Peg 및 아스코르베이트를 포함하는 조성물 |
| EP2895169A4 (en) * | 2012-09-12 | 2016-02-24 | Salix Pharmaceuticals Inc | METHODS OF ADMINISTERING RIFAXIMINE WITHOUT PRODUCING ANTIBIOTIC RESISTANCE |
| EP2894982A4 (en) * | 2012-09-13 | 2016-06-22 | Salix Pharmaceuticals Inc | METHODS OF IMPROVING LONG-TERM SURVIVAL AND REDUCING HOSPITAL RE-EMISSION RATES IN PATIENTS WITH HEPATIC ENCEPHALOPATHY |
| CA2903283C (en) | 2013-03-15 | 2023-09-05 | Braintree Laboratories, Inc. | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof |
| CN105307654B (zh) * | 2013-04-30 | 2022-06-07 | 托马斯·朱利叶斯·波洛迪 | 用于治疗微生物区系相关的精神病况和疾病的组合物和方法 |
| CA2912712A1 (en) * | 2013-05-17 | 2014-11-20 | Salix Pharmaceuticals, Inc. | Methods of using rifaximin in position emission tomography (pet) scans |
| WO2014201037A2 (en) * | 2013-06-10 | 2014-12-18 | New York University | Methods for manipulating immune responses by altering microbiota |
| KR101423005B1 (ko) | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
| US9387199B2 (en) * | 2013-11-12 | 2016-07-12 | University Of Virginia Patent Foundation | Compositions and methods for treating clostridium infection and preventing recurrence of infection |
| EP3122349B1 (en) | 2014-03-25 | 2021-12-22 | Leading Biosciences, Inc. | Compositions for the treatment of autodigestion |
| EA201692106A1 (ru) | 2014-04-29 | 2017-04-28 | КОЛОНАРИКОНСЕПТС ЭлЭлСи | Пищевые продукты, системы, способы и наборы для замены электролитов |
| CN106999477B (zh) * | 2014-06-30 | 2020-04-10 | 萨利克斯药品公司 | 用于重复治疗肠易激综合征(ibs)的方法 |
| HK1247283A1 (zh) | 2015-03-02 | 2018-09-21 | 科罗纳里康赛普茨有限责任公司 | 用於peg代谢物及peg分解产物检测的化合物及方法 |
| HRP20200432T1 (hr) | 2015-04-02 | 2020-06-12 | Theravance Biopharma R&D Ip, Llc | Oblik za kombinacijsko doziranje antagonista mu opioidnog receptora i opioidnog sredstva |
| KR102619907B1 (ko) * | 2015-08-17 | 2024-01-02 | 서화수 | 가축설사 치료용 복합제 조성물 |
| CA3010865A1 (en) * | 2016-01-08 | 2017-07-13 | Colonaryconcepts Llc | Food based delivery of therapeutic agent for treatment of hepatic encephalopathy |
| US10653728B2 (en) | 2016-10-17 | 2020-05-19 | New York University | Probiotic compositions for improving metabolism and immunity |
| PL3416627T3 (pl) * | 2017-04-26 | 2020-06-01 | Sandoz Ag | Doustna postać dawkowania zawierająca rifaksyminę w postaci beta |
| EP3737380A4 (en) * | 2018-01-11 | 2021-09-29 | Meritage Pharma, Inc. | STABLE CORTICOSTEROID COMPOSITIONS |
| WO2019178652A1 (en) * | 2018-03-23 | 2019-09-26 | Borody Thomas J | Compositions and methods for treating inflammatory bowel disease and fusobacteria-caused or related diseases and conditions |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3363997A (en) | 1958-12-22 | 1968-01-16 | Monsanto Co | Composition of matter and process |
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
| AU6196786A (en) | 1985-08-01 | 1987-03-05 | Braintree Laboratories Inc. | Low-sodium laxative and lavage formulation |
| DE3889547T2 (de) | 1987-12-24 | 1994-11-17 | Borody Thomas J | Orthostatische waschlösungen. |
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| DK1017404T3 (da) * | 1997-09-26 | 2004-11-01 | Celltech Pharma Europ Ltd | Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom |
| AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| JP2005526059A (ja) * | 2002-03-07 | 2005-09-02 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質組成物 |
| AU2003260736B8 (en) * | 2002-08-26 | 2009-04-23 | S.L.A. Pharma Ag | A pharmaceutical composition |
| GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
| SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
| WO2006102536A2 (en) | 2005-03-23 | 2006-09-28 | University Of Southern California | Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| AU2006244112B2 (en) * | 2005-05-06 | 2011-02-17 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
| ES2747259T3 (es) * | 2006-03-09 | 2020-03-10 | Salix Pharmaceuticals Inc | Preparación anti-disfunción rectal de rifaximina |
| US20100069421A1 (en) * | 2006-08-02 | 2010-03-18 | Doug Bettenhausen | Compositions and methods for the treatment of radiation proctosigmoitis |
| US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| EP2201372A4 (en) * | 2007-10-17 | 2010-11-10 | Salix Pharmaceuticals Ltd | NEW THERAPEUTIC TARGET MOLECULES IN STOMACH DISEASES |
| WO2019023892A1 (en) | 2017-07-31 | 2019-02-07 | SZ DJI Technology Co., Ltd. | MOTION-BASED IMPRESSION CORRECTION IN POINT CLOUDS |
| US11960008B2 (en) | 2018-05-17 | 2024-04-16 | Cmos Sensor, Inc. | Method and system for pseudo 3D mapping in robotic applications |
| KR102382079B1 (ko) | 2020-02-11 | 2022-03-31 | 효성중공업 주식회사 | 에어갭 조절장치 |
| US11963008B2 (en) | 2020-11-25 | 2024-04-16 | Truist Bank | Geolocation-based notifications using relationships in separate systems |
-
2009
- 2009-05-07 PL PL09743658T patent/PL2294012T3/pl unknown
- 2009-05-07 SI SI200931030T patent/SI2294012T1/sl unknown
- 2009-05-07 US US12/437,232 patent/US20090324736A1/en not_active Abandoned
- 2009-05-07 ES ES09743658.8T patent/ES2509892T3/es active Active
- 2009-05-07 PT PT97436588T patent/PT2294012E/pt unknown
- 2009-05-07 CA CA2723752A patent/CA2723752A1/en not_active Abandoned
- 2009-05-07 AU AU2009244190A patent/AU2009244190B2/en not_active Ceased
- 2009-05-07 EP EP09743658.8A patent/EP2294012B1/en active Active
- 2009-05-07 HR HRP20140939AT patent/HRP20140939T1/hr unknown
- 2009-05-07 WO PCT/US2009/043138 patent/WO2009137672A1/en not_active Ceased
- 2009-05-07 JP JP2011508663A patent/JP5752032B2/ja not_active Expired - Fee Related
- 2009-05-07 DK DK09743658.8T patent/DK2294012T3/da active
-
2012
- 2012-09-05 US US13/603,647 patent/US20130164384A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090324736A1 (en) | 2009-12-31 |
| EP2294012A4 (en) | 2011-10-26 |
| HK1156293A1 (en) | 2012-06-08 |
| PT2294012E (pt) | 2014-10-15 |
| HRP20140939T1 (hr) | 2014-11-21 |
| PL2294012T3 (pl) | 2014-12-31 |
| ES2509892T3 (es) | 2014-10-20 |
| EP2294012B1 (en) | 2014-07-09 |
| JP5752032B2 (ja) | 2015-07-22 |
| WO2009137672A1 (en) | 2009-11-12 |
| JP2011519952A (ja) | 2011-07-14 |
| AU2009244190A1 (en) | 2009-11-12 |
| SI2294012T1 (sl) | 2014-11-28 |
| AU2009244190B2 (en) | 2016-02-25 |
| EP2294012A1 (en) | 2011-03-16 |
| US20130164384A1 (en) | 2013-06-27 |
| CA2723752A1 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2294012T3 (pl) | Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit | |
| EP2132133A4 (en) | RELEASE OF PARTICULATE ACTIVE SUBSTANCES | |
| BRPI0807544A2 (pt) | Sólido farmacêutico e dose de vacina | |
| DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
| EP2212350A4 (en) | THERAPEUTIC AND DIAGNOSTIC PROCEDURES USING TIM-3 | |
| DK2073860T3 (da) | Lægemiddelfrigivende coatinger til medicinske indretninger | |
| DK2173407T3 (da) | Anordning til indgivelse af lægemiddel | |
| DK2399580T3 (da) | Farmaceutiske doseringsformer | |
| FI20095180A7 (fi) | Lääketieteellinen harjoituslaite | |
| CY2016053I1 (el) | Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας | |
| BRPI0820381A2 (pt) | Formulações farmacêuticas | |
| DK1983964T3 (da) | Anordning til indgivelse af lægemiddel | |
| DK3067066T3 (da) | Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom | |
| EP1992348A4 (en) | PHARMACEUTICAL COMBINATION | |
| EP1972256A4 (en) | ENDOSCOPE AND ROTATING SELF-DRIVEN ENDOSCOPE | |
| DK2035369T3 (da) | Terapeutiske | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| EP2081520A4 (en) | MEDICAL IMPLANTS | |
| HUE062920T2 (hu) | Eljárások vakcina beadására | |
| EP2052757A4 (en) | MEDICAL CAPSULE | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| DK2029561T3 (da) | Tricyclisk forbindelse og farmaceutisk anvendelse deraf | |
| DK2296651T3 (da) | 5-hydroxymethyl-oxazolidin-2-on-derivater til behandling af bakterielle intestinale sygdomme | |
| BRPI0820449A2 (pt) | Conjunto de implante médico interfaceado |